Allison Portnoy
Profiles

Allison Portnoy, ScD

Assistant Professor, Global Health - Boston University School of Public Health

(617) 358-0041
aportnoy@bu.edu
Crosstown Center
View Full Profile at BUMC

Biography

Dr. Allison Portnoy is an assistant professor of global health focused on vaccine decision science and policy. Her research includes economic evaluation and public health policy, simulation modeling, health equity, and the impact of vaccination on population health and economic outcomes. She is particularly interested in broadening the value of vaccination in high-burden settings. Her ongoing work spans multiple diseases areas, including human papillomavirus (HPV), measles, and tuberculosis (TB).

Dr. Portnoy received a Doctor of Science from the Department of Global Health and Population and completed a postdoctoral fellowship at the Center for Health Decision Science, both at the Harvard T.H. Chan School of Public Health. Her previous education includes an MSPH in Health Policy & Management from the Johns Hopkins Bloomberg School of Public Health and a BA in International Relations from Stanford University. She previously worked as a health economist at the International Vaccine Access Center at Johns Hopkins, and conducted research projects with the World Health Organization, Agency for Healthcare Research and Quality, and the University of Washington in Seattle.

Education

  • Harvard School of Public Health, ScD Field of Study: Global Health

Websites

Publications

  • Published on 9/13/2024

    Lambach P, Silal S, Sbarra AN, Crowcroft NS, Frey K, Ferrari M, Vynnycky E, Metcalf CJE, Winter AK, Zimmerman L, Koh M, Sheel M, Kim SY, Munywoki PK, Portnoy A, Aggarwal R, Farooqui HH, Flasche S, Hogan AB, Leung K, Moss WJ, Wang XY. Report from the World Health Organization's immunization and vaccines-related implementation research advisory committee (IVIR-AC) ad hoc meeting, 28 June - 1 July 2024. Vaccine. 2024 Sep 13; 42(26):126307. PMID: 39276622.

     Read At: PubMed
  • Published on 9/13/2024

    Gaythorpe KAM, Li X, Clapham H, Dansereau E, Fitzjohn R, Hinsley W, Hogan D, Jit M, Mengistu T, Perkins TA, Portnoy A, Vynnycky E, Woodruff K, Ferguson NM, Trotter CL. Estimating the impact of vaccination: lessons learned in the first phase of the Vaccine Impact Modelling Consortium. Gates Open Res. 2024; 8:97. PMID: 39398325.

     Read At: PubMed
  • Published on 7/11/2024

    Lambach P, Silal S, Sbarra AN, Koh M, Aggarwal R, Farooqui HH, Flasche S, Hogan AB, Kim SY, Leung K, Moss WJ, Munywoki PK, Portnoy A, Sheel M, Wang XY. Corrigendum to "Report from the World Health Organization's immunization and vaccines-related implementation research advisory committee (IVIR-AC) meeting, virtual gathering, 26 February-1 March 2024" [Vaccine 42(15) (2024) 3379-3383]. Vaccine. 2024 Oct 03; 42(23):126102. PMID: 38991915.

     Read At: PubMed
  • Published on 6/3/2024

    Clarke-Deelder E, Suharlim C, Chatterjee S, Portnoy A, Brenzel L, Ray A, Cohen JL, Menzies NA, Resch SC. Health impact and cost-effectiveness of expanding routine immunization coverage in India through Intensified Mission Indradhanush. Health Policy Plan. 2024 Jun 03; 39(6):583-592. PMID: 38590052.

     Read At: PubMed
  • Published on 5/3/2024

    Lambach P, Silal S, Sbarra AN, Koh M, Aggarwal R, Farooqui HH, Flasche S, Hogan AB, Kim SY, Leung K, Moss WJ, Munywoki PK, Portnoy A, Sheel M, Wang XY. Report from the World Health Organization's immunization and vaccines-related implementation research advisory committee (IVIR-AC) meeting, virtual gathering, 26 February-1 March 2024. Vaccine. 2024 May 31; 42(15):3379-3383. PMID: 38704250.

     Read At: PubMed
  • Published on 4/20/2024

    Portnoy A, Pedersen K, Kim JJ, Burger EA. Vaccination and screening strategies to accelerate cervical cancer elimination in Norway: a model-based analysis. Br J Cancer. 2024 Jun; 130(12):1951-1959. PMID: 38643338.

     Read At: PubMed
  • Published on 4/18/2024

    White RG, Menzies NA, Portnoy A, Clark RA, Toscano CM, Weller C, Tufet Bayona M, Silal SP, Karron RA, Lee JS, Excler JL, Lauer JA, Giersing B, Lambach P, Hutubessy R, Jit M. The Full Value of Vaccine Assessments Concept-Current Opportunities and Recommendations. Vaccines (Basel). 2024 Apr 18; 12(4). PMID: 38675817.

     Read At: PubMed
  • Published on 4/1/2024

    Hartner AM, Li X, Echeverria-Londono S, Roth J, Abbas K, Auzenbergs M, de Villiers MJ, Ferrari MJ, Fraser K, Fu H, Hallett T, Hinsley W, Jit M, Karachaliou A, Moore SM, Nayagam S, Papadopoulos T, Perkins TA, Portnoy A, Minh QT, Vynnycky E, Winter AK, Burrows H, Chen C, Clapham HE, Deshpande A, Hauryski S, Huber J, Jean K, Kim C, Kim JH, Koh J, Lopman BA, Pitzer VE, Tam Y, Lambach P, Sim SY, Woodruff K, Ferguson NM, Trotter CL, Gaythorpe KAM. Estimating the health effects of COVID-19-related immunisation disruptions in 112 countries during 2020-30: a modelling study. Lancet Glob Health. 2024 Apr; 12(4):e563-e571. PMID: 38485425.

     Read At: PubMed
  • Published on 2/2/2024

    Sumner T, Clark RA, Mukandavire C, Portnoy A, Weerasuriya CK, Bakker R, Scarponi D, Hatherill M, Menzies NA, White RG. Modelling the health and economic impacts ofM72/AS01E vaccination and BCG-revaccination: Estimates for South Africa. Vaccine. 2024 Feb 27; 42(6):1311-1318. PMID: 38307747.

     Read At: PubMed
  • Published on 12/13/2023

    Portnoy A, Pedersen K, Sy S, Tropé A, Engesaeter B, Kim JJ, Burger EA. Cost-effectiveness of primary human papillomavirus triage approaches among vaccinated women in Norway: A model-based analysis. Int J Cancer. 2024 Mar 15; 154(6):1073-1081. PMID: 38088449.

     Read At: PubMed

View 48 more publications:View Full Profile at BUMC

News & In the Media

View all profiles